Sign up to save your podcasts
Or
Share Novel Incretin-Based Dual/Triple Agonists: The Future in Diabetes Care?
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Novel Incretin-Based Dual/Triple Agonists: The Future in Diabetes Care?
How much do you know about future treatment options for type 2 diabetes (T2D)? Join Drs Vilsbøll and Nauck to find out. Credit available for this activity expires: 03/27/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000462 ?ecd=bdc_podcast_libsyn_mscpedu
View all episodes
By Medscape Podcasts
4
77 ratings
How much do you know about future treatment options for type 2 diabetes (T2D)? Join Drs Vilsbøll and Nauck to find out. Credit available for this activity expires: 03/27/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000462 ?ecd=bdc_podcast_libsyn_mscpedu
More shows like Keeping Current
View all
JAMA Editors' Summary
140 Listeners
The Bob Harrington Show
13 Listeners
NEJM This Week
324 Listeners
Diabetes Core Update
106 Listeners
This Week in Cardiology
873 Listeners
Core EM - Emergency Medicine Podcast
251 Listeners
JAMA Clinical Reviews
506 Listeners
AFP: American Family Physician Podcast
694 Listeners
One-on-One with Eric Topol
17 Listeners
Mayo Clinic Talks
282 Listeners
The Curbsiders Internal Medicine Podcast
3,336 Listeners
Core IM | Internal Medicine Podcast
1,117 Listeners
Annals On Call Podcast
196 Listeners
The Clinical Problem Solvers
516 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
362 Listeners
Medicine and the Machine
61 Listeners
Keeping Current CME
25 Listeners
Cardionerds: A Cardiology Podcast
422 Listeners
The Curious Clinicians
367 Listeners